In HD, mHTT disrupts microglial proteostasis, impairing synaptic support and promoting striatal inflammation, while ALS reveals that microglial activation in motor cortices correlates with TDP-43 pathology and cognitive decline. Here, TARDBP is linked to Huntington disease.